Natus Medical Incorporated Company Profile (NASDAQ:BABY)

About Natus Medical Incorporated (NASDAQ:BABY)

Natus Medical Incorporated logoNatus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders. The Company's product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products, such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, incubators to control the newborn's environment, and software systems for managing and tracking disorders and diseases for public health laboratories. The Company is organized into three strategic business units: Neurology, Newborn Care and Otometrics.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Advanced Medical Equipment & Technology
  • Sub-Industry: Health Care Equipment
  • Symbol: NASDAQ:BABY
  • CUSIP: 63905010
  • Web: www.natus.com
Capitalization:
  • Market Cap: $1.31 billion
  • Outstanding Shares: 32,528,000
Average Prices:
  • 50 Day Moving Avg: $37.32
  • 200 Day Moving Avg: $36.10
  • 52 Week Range: $31.65 - $43.85
P/E:
  • Trailing P/E Ratio: 69.67
  • Foreward P/E Ratio: 20.30
  • P/E Growth: 1.07
Sales & Book Value:
  • Annual Revenue: $445.49 million
  • Price / Sales: 2.94
  • Book Value: $13.11 per share
  • Price / Book: 3.07
Profitability:
  • EBITDA: $48 million
  • Net Margins: 4.20%
  • Return on Equity: 12.09%
  • Return on Assets: 8.06%
Debt:
  • Debt-to-Equity Ratio: 0.26%
  • Current Ratio: 3.33%
  • Quick Ratio: 2.52%
Misc:
  • Average Volume: 373,151 shs.
  • Beta: 0.95
  • Short Ratio: 6.68
 

Frequently Asked Questions for Natus Medical Incorporated (NASDAQ:BABY)

What is Natus Medical Incorporated's stock symbol?

Natus Medical Incorporated trades on the NASDAQ under the ticker symbol "BABY."

How were Natus Medical Incorporated's earnings last quarter?

Natus Medical Incorporated (NASDAQ:BABY) posted its quarterly earnings results on Wednesday, July, 26th. The company reported $0.34 EPS for the quarter, topping analysts' consensus estimates of $0.33 by $0.01. The business earned $122.20 million during the quarter, compared to analysts' expectations of $121.99 million. Natus Medical Incorporated had a return on equity of 12.09% and a net margin of 4.20%. Natus Medical Incorporated's quarterly revenue was up 27.3% on a year-over-year basis. During the same quarter last year, the company posted $0.39 earnings per share. View Natus Medical Incorporated's Earnings History.

When will Natus Medical Incorporated make its next earnings announcement?

Natus Medical Incorporated is scheduled to release their next quarterly earnings announcement on Wednesday, October, 25th 2017. View Earnings Estimates for Natus Medical Incorporated.

What guidance has Natus Medical Incorporated issued on next quarter's earnings?

Natus Medical Incorporated issued an update on its FY17 earnings guidance on Wednesday, July, 26th. The company provided earnings per share (EPS) guidance of $1.70-1.75 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.70. The company issued revenue guidance of $505-510 million, compared to the consensus revenue estimate of $504.56 million.Natus Medical Incorporated also updated its Q3 guidance to $0.37-0.38 EPS.

Where is Natus Medical Incorporated's stock going? Where will Natus Medical Incorporated's stock price be in 2017?

3 brokerages have issued 1 year price targets for Natus Medical Incorporated's stock. Their predictions range from $48.00 to $48.00. On average, they anticipate Natus Medical Incorporated's share price to reach $48.00 in the next twelve months. View Analyst Ratings for Natus Medical Incorporated.

Who are some of Natus Medical Incorporated's key competitors?

Who are Natus Medical Incorporated's key executives?

Natus Medical Incorporated's management team includes the folowing people:

  • Robert A. Gunst, Independent Chairman of the Board
  • James B. Hawkins, President, Chief Executive Officer, Director
  • Jonathan A. Kennedy, Chief Financial Officer, Executive Vice President, IR Contact Officer
  • Austin F. Noll III, Vice President and General Manager - Neurology Strategic Business Unit
  • D. Christopher Chung M.D., Vice President - Medical Affairs, Quality & Regulatory
  • Doris E. Engibous, Independent Director
  • Kenneth E. Ludlum, Independent Director
  • William M. Moore Jr., Independent Director
  • Barbara R. Paul M.D., Independent Director

Who owns Natus Medical Incorporated stock?

Natus Medical Incorporated's stock is owned by many different of institutional and retail investors. Top institutional investors include Diamond Hill Capital Management Inc. (1.63%), Nationwide Fund Advisors (0.98%), Strs Ohio (0.34%) and Eqis Capital Management Inc. (0.05%). Company insiders that own Natus Medical Incorporated stock include Austin Francis Noll III, Dong Chune Christopher Chung, Doris Engibous, James B Hawkins, Jonathan Kennedy, Ken Ludlum, Kenneth M Traverso, Robert A Gunst and William M Moore. View Institutional Ownership Trends for Natus Medical Incorporated.

Who sold Natus Medical Incorporated stock? Who is selling Natus Medical Incorporated stock?

Natus Medical Incorporated's stock was sold by a variety of institutional investors in the last quarter, including Nationwide Fund Advisors and Diamond Hill Capital Management Inc.. Company insiders that have sold Natus Medical Incorporated stock in the last year include Doris Engibous, Jonathan Kennedy, Robert A Gunst and William M Moore. View Insider Buying and Selling for Natus Medical Incorporated.

Who bought Natus Medical Incorporated stock? Who is buying Natus Medical Incorporated stock?

Natus Medical Incorporated's stock was acquired by a variety of institutional investors in the last quarter, including Strs Ohio and Eqis Capital Management Inc.. View Insider Buying and Selling for Natus Medical Incorporated.

How do I buy Natus Medical Incorporated stock?

Shares of Natus Medical Incorporated can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Natus Medical Incorporated's stock price today?

One share of Natus Medical Incorporated stock can currently be purchased for approximately $40.20.


MarketBeat Community Rating for Natus Medical Incorporated (NASDAQ BABY)
Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  124 (Vote Outperform)
Underperform Votes:  105 (Vote Underperform)
Total Votes:  229
MarketBeat's community ratings are surveys of what our community members think about Natus Medical Incorporated and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Natus Medical Incorporated (NASDAQ:BABY) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Sell Rating, 1 Hold Rating, 1 Buy Rating
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $48.00 (19.40% upside)
Consensus Price Target History for Natus Medical Incorporated (NASDAQ:BABY)
Price Target History for Natus Medical Incorporated (NASDAQ:BABY)
Analysts' Ratings History for Natus Medical Incorporated (NASDAQ:BABY)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
5/1/2017Benchmark Co.Reiterated RatingBuy -> Buy$55.00 -> $48.00MediumView Rating Details
2/2/2017Raymond James Financial, Inc.DowngradeOutperform -> Market PerformN/AView Rating Details
12/16/2016Off Wall StreetInitiated CoverageSellN/AView Rating Details
4/21/2016Roth CapitalReiterated RatingBuyN/AView Rating Details
(Data available from 10/23/2015 forward)

Earnings

Earnings History for Natus Medical Incorporated (NASDAQ:BABY)
Earnings by Quarter for Natus Medical Incorporated (NASDAQ:BABY)
Earnings History by Quarter for Natus Medical Incorporated (NASDAQ BABY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/25/2017$0.38N/AView Earnings Details
7/26/2017Q2 2017$0.33$0.34$121.99 million$122.20 millionViewN/AView Earnings Details
4/26/2017Q1 2017$0.33$0.30$122.45 million$124.70 millionViewN/AView Earnings Details
2/1/2017Q416$0.53$0.51$107.58 million$107.70 millionViewListenView Earnings Details
10/19/2016Q316$0.34$0.39$89.94 million$90.90 millionViewListenView Earnings Details
7/20/2016Q216$0.36$0.39$92.71 million$96.00 millionViewListenView Earnings Details
4/20/2016Q116$0.30$0.34$90.47 million$87.30 millionViewListenView Earnings Details
1/27/2016Q415$0.46$0.51$100.88 million$100.00 millionViewListenView Earnings Details
10/21/2015Q315$0.38$0.39$93.70 million$94.60 millionViewListenView Earnings Details
7/22/2015Q215$0.32$0.34$90.83 million$91.90 millionViewListenView Earnings Details
4/22/2015Q115$0.29$0.31$88.93 million$89.40 millionViewListenView Earnings Details
1/28/2015Q414$0.38$0.40$93.28 million$94.00 millionViewListenView Earnings Details
10/22/2014Q314$0.31$0.33$87.30 million$89.90 millionViewListenView Earnings Details
7/23/2014Q214$0.26$0.28$84.85 million$86.30 millionViewListenView Earnings Details
4/23/2014Q114$0.23$0.26$84.70 million$85.60 millionViewListenView Earnings Details
1/29/2014Q413$0.32$0.37$89.12 million$90.60 millionViewListenView Earnings Details
10/24/2013Q313$0.19$0.30$80.83 million$85.40 millionViewListenView Earnings Details
8/1/2013Q2 2013$0.14$0.21$83.50 million$82.30 millionViewListenView Earnings Details
5/20/2013Q1 2013$0.11$0.15$84.47 million$85.80 millionViewListenView Earnings Details
2/28/2013Q4 2012$0.26$0.29$93.60 million$90.50 millionViewListenView Earnings Details
11/7/2012$0.14$0.15$81.37 million$80.70 millionViewN/AView Earnings Details
7/26/2012$0.11$0.12ViewN/AView Earnings Details
4/26/2012$0.05$0.07ViewN/AView Earnings Details
2/28/2012$0.12$0.14ViewN/AView Earnings Details
10/27/2011$0.06$0.07ViewN/AView Earnings Details
7/28/2011$0.18$0.13ViewN/AView Earnings Details
4/28/2011$0.11$0.13ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Natus Medical Incorporated (NASDAQ:BABY)
2017 EPS Consensus Estimate: $1.80
2018 EPS Consensus Estimate: $2.01
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171$0.32$0.32$0.32
Q2 20171$0.38$0.38$0.38
Q3 20171$0.42$0.42$0.42
Q4 20172$0.68$0.68$0.68
Q1 20181$0.39$0.39$0.39
Q2 20181$0.48$0.48$0.48
Q3 20181$0.49$0.49$0.49
Q4 20181$0.65$0.65$0.65
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Natus Medical Incorporated (NASDAQ:BABY)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Natus Medical Incorporated (NASDAQ:BABY)
Insider Ownership Percentage: 5.50%
Institutional Ownership Percentage: 92.66%
Insider Trades by Quarter for Natus Medical Incorporated (NASDAQ:BABY)
Institutional Ownership by Quarter for Natus Medical Incorporated (NASDAQ:BABY)
Insider Trades by Quarter for Natus Medical Incorporated (NASDAQ:BABY)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/14/2017Robert A GunstDirectorSell4,400$35.17$154,748.00View SEC Filing  
8/14/2017William M MooreDirectorSell3,000$34.10$102,300.00View SEC Filing  
6/15/2017James B HawkinsInsiderBuy4,000$33.98$135,920.00View SEC Filing  
5/31/2017James B. HawkinsInsiderBuy6,000$33.81$202,860.00View SEC Filing  
5/25/2017Doris EngibousDirectorSell5,000$32.68$163,400.00View SEC Filing  
2/9/2017Robert A GunstDirectorSell5,000$36.00$180,000.00View SEC Filing  
12/16/2016James B HawkinsInsiderBuy10,000$35.20$352,000.00View SEC Filing  
10/27/2016James B HawkinsInsiderBuy10,000$38.30$383,000.00View SEC Filing  
10/25/2016Jonathan KennedyCFOSell30,276$41.40$1,253,426.40View SEC Filing  
10/24/2016Jonathan KennedyCFOSell14,138$41.61$588,282.18View SEC Filing  
10/24/2016Robert A GunstDirectorSell3,250$41.92$136,240.00View SEC Filing  
9/28/2016James B HawkinsInsiderBuy10,000$38.48$384,800.00View SEC Filing  
4/26/2016Robert A GunstDirectorSell5,000$34.61$173,050.00View SEC Filing  
4/22/2016Doris EngibousDirectorSell5,000$32.68$163,400.00View SEC Filing  
4/22/2016Kenneth M TraversoVPSell7,459$33.56$250,324.04View SEC Filing  
2/17/2016Ken LudlumDirectorSell6,625$33.02$218,757.50View SEC Filing  
12/9/2015Dong Chune Christopher ChungVPSell14,000$48.78$682,920.00View SEC Filing  
11/27/2015James B. HawkinsCEOSell57,511$49.09$2,823,214.99View SEC Filing  
11/25/2015Austin Francis Noll IIIVPSell38,875$48.40$1,881,550.00View SEC Filing  
11/12/2015James B. HawkinsCEOSell42,489$47.62$2,023,326.18View SEC Filing  
10/30/2015James B. HawkinsCEOSell100,000$45.75$4,575,000.00View SEC Filing  
10/28/2015Dong Chune Christopher ChungVPSell26,000$45.73$1,188,980.00View SEC Filing  
10/28/2015Jonathan KennedyCFOSell28,958$45.72$1,323,959.76View SEC Filing  
9/15/2015William M MooreDirectorSell5,994$40.76$244,315.44View SEC Filing  
9/14/2015William M MooreDirectorSell4,000$40.27$161,080.00View SEC Filing  
9/8/2015William M MooreDirectorSell3,006$40.09$120,510.54View SEC Filing  
8/18/2015William M MooreDirectorSell3,000$45.62$136,860.00View SEC Filing  
8/13/2015William M MooreDirectorSell4,000$45.55$182,200.00View SEC Filing  
7/24/2015Robert A GunstDirectorSell4,000$45.30$181,200.00View SEC Filing  
6/15/2015William M MooreDirectorSell6,000$41.30$247,800.00View SEC Filing  
6/8/2015James B HawkinsCEOSell100,000$42.08$4,208,000.00View SEC Filing  
6/3/2015Dong Chune Christopher ChungVPSell26,000$41.01$1,066,260.00View SEC Filing  
4/28/2015Kenneth M TraversoVPSell57,233$40.80$2,335,106.40View SEC Filing  
4/24/2015Doris EngibousDirectorSell15,000$42.20$633,000.00View SEC Filing  
2/3/2015Dong Chune Christopher ChungVPSell40,000$36.64$1,465,600.00View SEC Filing  
12/9/2014Jonathan KennedyCFOSell45,833$35.67$1,634,863.11View SEC Filing  
12/8/2014William M MooreDirectorSell4,451$34.65$154,227.15View SEC Filing  
12/5/2014William M MooreDirectorSell561$34.65$19,438.65View SEC Filing  
12/2/2014William M MooreDirectorSell2,278$3,478.00$7,922,884.00View SEC Filing  
11/4/2014James B HawkinsCEOSell18,400$34.10$627,440.00View SEC Filing  
10/30/2014Robert A GunstDirectorSell15,000$33.92$508,800.00View SEC Filing  
10/28/2014Dong Chune Christopher ChungVPSell50,000$33.14$1,657,000.00View SEC Filing  
10/28/2014James B HawkinsCEOSell251,600$33.31$8,380,796.00View SEC Filing  
10/27/2014Dong Chune Christopher ChungVPSell39,521$33.09$1,307,749.89View SEC Filing  
10/24/2014Kenneth M TraversoVPSell30,000$33.33$999,900.00View SEC Filing  
9/10/2014William M MooreDirectorSell2,200$29.30$64,460.00View SEC Filing  
9/8/2014William M MooreDirectorSell5,000$29.17$145,850.00View SEC Filing  
7/30/2014Austin Francis Noll IIIVPSell23,500$29.42$691,370.00View SEC Filing  
5/30/2014Ken LudlumDirectorSell2,500$24.77$61,925.00View SEC Filing  
2/24/2014James HawkinsCEOSell75,000$25.88$1,941,000.00View SEC Filing  
2/13/2014James HawkinsCEOSell96,046$24.77$2,379,059.42View SEC Filing  
2/4/2014James HawkinsCEOSell16,910$25.93$438,476.30View SEC Filing  
12/4/2013James HawkinsCEOSell206,878$22.58$4,671,305.24View SEC Filing  
10/29/2013Kenneth M TraversoVPSell25,000$19.54$488,500.00View SEC Filing  
9/12/2013Doris EngibousDirectorSell33,750$13.53$456,637.50View SEC Filing  
9/12/2013Kenneth M TraversoVPSell4,225$13.89$58,685.25View SEC Filing  
8/19/2013Dong Chune Christopher ChungVPSell5,818$12.78$74,354.04View SEC Filing  
8/19/2013James HawkinsCEOSell22,190$12.78$283,588.20View SEC Filing  
6/5/2013Kenneth M TraversoVPSell22,682$14.30$324,352.60View SEC Filing  
6/3/2013Kenneth M TraversoVPSell7,318$14.50$106,111.00View SEC Filing  
5/28/2013Steven J MurphyVPSell10,000$14.42$144,200.00View SEC Filing  
3/12/2013Robert A GunstDirectorBuy5,000$13.40$67,000.00View SEC Filing  
11/27/2012Robert A GunstDirectorBuy10,000$11.66$116,600.00View SEC Filing  
11/9/2012Kenneth M TraversoVPSell49,885$11.19$558,213.15View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Natus Medical Incorporated (NASDAQ:BABY)
Latest Headlines for Natus Medical Incorporated (NASDAQ:BABY)
Source:
Loading headlines, please wait.

Social

Chart

Natus Medical Incorporated (BABY) Chart for Monday, October, 23, 2017

This page was last updated on 10/23/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.